Test Price
2,800 AEDโ Home Collection Available
MAF Gene Cataract (Pulverulent/Cerulean) with or without Microcornea โ Genetic Test in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity verified through ISO 15189 and ISO 9001:2015 accredited processes.
- Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic post-test genetic counselling provided by a DHA-licensed consultant medical geneticist.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This next-generation sequencing (NGS) test analyzes the entire MAF gene to detect pathogenic variants responsible for congenital pulverulent or cerulean cataracts, with or without microcornea. The methodology includes a full gene coverage and copy number variant (CNV) detection, providing high diagnostic yield for affected individuals and at-risk family members.
| Feature | Our NGS MAF Test (UAE) | Closest Alternative (Sanger) |
|---|---|---|
| Precision | 99.9% sensitivity, full gene + CNV detection | ~95% for point mutations only |
| Methodology | NGS (LCโMS/MS verified) | Sanger sequencing (exonโspecific) |
| Turnaround Time | 3โ4 Weeks | 6โ8 Weeks |
| Home Collection | VIP Phlebotomy 8 AMโ11 PM | Not Available |
| Price | 2,800 AED | 1,800โ2,200 AED (abroad) |
Physician Insight & Safety Protocols
โA precise molecular diagnosis of MAF-related cataract empowers families with clarity for surgical timing and recurrence risk assessment. This test should be integrated with a comprehensive ophthalmological examination and genetic counselling.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory: Medication Safety
Do not discontinue or alter any prescribed medication without prior consultation with your treating physician. This genetic test provides diagnostic information and does not replace ongoing medical management.
Exclusion Criteria & Emergency Red Flags
- This test is not a substitute for acute ophthalmological evaluation. A prior specialist consultation is mandatory.
- Exclusion: Patients without clinical signs of congenital cataract or a family history suggestive of MAF mutations.
- Emergency red flags: Sudden painless vision loss, severe ocular pain, acute photophobia, or abrupt pupil change โ seek immediate emergency care.
- Minors require legal guardian consent in compliance with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What does a positive MAF gene test result mean for my childโs vision?
A positive result indicates a disease-causing mutation in the MAF gene, confirming a genetic basis for congenital cataracts with or without microcornea. This finding guides early surgical intervention and genetic counselling for the entire family.
2. Who should consider MAF gene testing in the UAE?
Any individual with bilateral congenital cataracts of pulverulent or cerulean morphology and/or microcornea, or a family history of early-onset cataracts, should undergo MAF gene testing. At-risk relatives seeking reassurance are also candidates.
3. How is the DNA sample collected for this test?
Sample collection involves a simple, near-painless blood draw (3 mL in EDTA tube) or a single drop of blood on an FTA card. Collection is performed by a DHA-licensed phlebotomist at your home or clinic through our VIP mobile phlebotomy service available 8 AMโ11 PM daily.
UAE Regulatory & Data Privacy Adherence
This test is performed at a DHA-licensed laboratory facility (License No. 1143) in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data handling respects the highest standards of confidentiality and patient consent obligations under UAE law.
Clinical & Logistical Metadata
| Test Name | MAF Gene Cataract (Pulverulent/Cerulean) with or without Microcornea โ Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 weeks from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or FTA card |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV detection |
| ICD-10-CM Code | Q12.0, Q13.1 |
| LOINC Code | 81265-5 |
| DHA Facility License & Laboratory Address | License No. 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians